UBA1 mutations (VEXAS syndrome) (bone marrow)

There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the HGTA (Federal Act on Human Genetic Testing) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).